Turkey
Stembio Cell and Tissue Technologies Inc., founded in 2020, is a Turkish company at the forefront of the biotechnology and healthcare industries. Guided by their slogan, "Our purpose is to build a leading, focused ATMPs company powered by advanced therapy products and data science," they are committed to pioneering developments in Advanced Therapy Medicinal Products (ATMPs).
The company focuses on the innovative potential of cell-based medicinal products, which are poised to address previously unmet medical needs. Their portfolio includes human cells of both allogeneic and autologous origins, cellular components, genetically modified cells, and cord blood banking. These advancements promise revolutionary treatments for a variety of diseases.
Stembio has not received any recent investment, presenting a fresh opportunity for investors looking to capitalize on the exponentially growing biotechnology sector. Positioned in a fertile market space, this company represents a strategic entry point into the emerging field of advanced therapy products.
